China Pharma Holdings (CPHI) Change in Intangibles (2010 - 2014)
China Pharma Holdings (CPHI) posted Change in Intangibles of -$470624.0 for Q4 2014, down 337.69% on a QoQ basis from $198003.0 in Q4 2013, and down 337.69% year-over-year from $198003.0 in Q4 2013.
China Pharma Holdings (CPHI) Change in Intangibles (2010 - 2014) Analysis & Trends
China Pharma Holdings' Change in Intangibles history runs 5 years deep, the most recent figure standing at -$470624.0 for Q4 2014.
- Quarterly Change in Intangibles fell 337.69% year-over-year to -$470624.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $3.3 million (up 10.63% YoY) and the FY2014 annual result came in at -$714697.0, down 139.32% from the prior year.
- Change in Intangibles was -$470624.0 for Q4 2014 at China Pharma Holdings, down from $198003.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $4.1 million in Q3 2013 and bottomed at -$4.9 million in Q3 2010.
- A 5-year average of -$1.0 million and a median of -$790092.0 in 2012 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2011 — Change in Intangibles jumped 75.71% — and 2012, when it plunged 705.78%.
- China Pharma Holdings' Change in Intangibles stood at -$3.5 million in 2010, then soared by 75.71% to -$856895.0 in 2011, then soared by 43.95% to -$480307.0 in 2012, then soared by 141.22% to $198003.0 in 2013, then tumbled by 337.69% to -$470624.0 in 2014.
- Business Quant data shows CPHI's Change in Intangibles at -$470624.0 in Q4 2014, $198003.0 in Q4 2013, and $4.1 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -470,624.00 |
| Dec 31, 2014 | -470,624.00 |
| Dec 31, 2013 | 198,003.00 |
| Dec 31, 2013 | 198,003.00 |
| Sep 30, 2013 | 4.08 Mn |
| Sep 30, 2013 | 4.08 Mn |
| Jun 30, 2012 | -480,307.00 |
| Jun 30, 2012 | -480,307.00 |
| Mar 31, 2012 | -790,092.00 |
| Mar 31, 2012 | -790,092.00 |
| Dec 31, 2011 | -856,895.00 |
| Dec 31, 2011 | -856,895.00 |
| Sep 30, 2011 | -3.43 Mn |
| Sep 30, 2011 | -3.43 Mn |
| Jun 30, 2011 | -59,608.00 |
| Jun 30, 2011 | -59,608.00 |
| Mar 31, 2011 | -843,378.00 |
| Mar 31, 2011 | -843,378.00 |
| Dec 31, 2010 | -3.53 Mn |
| Dec 31, 2010 | -3.53 Mn |